CLASSYS Past Earnings Performance
Past criteria checks 3/6
CLASSYS has been growing earnings at an average annual rate of 23.1%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 23.3% per year. CLASSYS's return on equity is 24.8%, and it has net margins of 39.4%.
Key information
23.1%
Earnings growth rate
22.9%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 23.3% |
Return on equity | 24.8% |
Net Margin | 39.4% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
CLASSYS Inc.'s (KOSDAQ:214150) Stock Retreats 25% But Earnings Haven't Escaped The Attention Of Investors
Nov 14We Think CLASSYS (KOSDAQ:214150) Can Stay On Top Of Its Debt
Jun 08CLASSYS Inc.'s (KOSDAQ:214150) 27% Jump Shows Its Popularity With Investors
May 21Capital Investment Trends At CLASSYS (KOSDAQ:214150) Look Strong
Apr 24Here's Why I Think CLASSYS (KOSDAQ:214150) Is An Interesting Stock
Apr 09When Should You Buy CLASSYS Inc. (KOSDAQ:214150)?
Mar 09Is CLASSYS Inc.'s (KOSDAQ:214150) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 17CLASSYS Inc. (KOSDAQ:214150) Shares Could Be 29% Below Their Intrinsic Value Estimate
Feb 02The Trend Of High Returns At CLASSYS (KOSDAQ:214150) Has Us Very Interested
Jan 17Here's Why I Think CLASSYS (KOSDAQ:214150) Might Deserve Your Attention Today
Jan 04The CLASSYS (KOSDAQ:214150) Share Price Has Gained 271%, So Why Not Pay It Some Attention?
Dec 22Is Now The Time To Look At Buying CLASSYS Inc. (KOSDAQ:214150)?
Dec 09What Type Of Shareholders Own The Most Number of CLASSYS Inc. (KOSDAQ:214150) Shares?
Nov 26Revenue & Expenses Breakdown
How CLASSYS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 215,540 | 84,857 | 47,971 | 11,289 |
30 Jun 24 | 204,373 | 89,562 | 43,707 | 10,426 |
31 Mar 24 | 191,528 | 81,540 | 41,231 | 9,885 |
31 Dec 23 | 180,123 | 74,225 | 38,725 | 9,201 |
30 Sep 23 | 173,586 | 88,565 | 36,932 | 7,926 |
30 Jun 23 | 158,609 | 86,088 | 34,518 | 6,717 |
31 Mar 23 | 145,395 | 81,337 | 31,885 | 5,453 |
31 Dec 22 | 141,803 | 75,379 | 32,629 | 4,430 |
30 Sep 22 | 126,656 | 55,021 | 29,194 | 4,097 |
30 Jun 22 | 117,853 | 48,828 | 26,379 | 4,326 |
31 Mar 22 | 114,658 | 47,059 | 23,571 | 4,993 |
31 Dec 21 | 100,597 | 43,805 | 19,992 | 4,701 |
30 Sep 21 | 96,154 | 47,339 | 18,874 | 5,296 |
30 Jun 21 | 91,252 | 43,642 | 18,886 | 4,064 |
31 Mar 21 | 76,352 | 36,323 | 18,288 | 2,862 |
31 Dec 20 | 76,461 | 38,165 | 16,089 | 3,115 |
30 Sep 20 | 77,904 | 35,280 | 15,475 | 2,067 |
30 Jun 20 | 79,398 | 35,964 | 16,636 | 2,067 |
31 Mar 20 | 86,369 | 38,872 | 18,267 | 2,107 |
31 Dec 19 | 81,133 | 33,394 | 19,255 | 1,924 |
30 Sep 19 | 73,396 | 29,300 | 19,218 | 1,493 |
30 Jun 19 | 63,949 | 22,626 | 18,348 | 1,493 |
31 Mar 19 | 53,844 | 18,848 | 16,081 | 1,379 |
31 Dec 18 | 47,482 | 14,863 | 14,987 | 1,529 |
30 Sep 18 | 40,912 | -3,632 | 14,012 | 1,753 |
30 Jun 18 | 37,817 | -4,315 | 12,792 | 1,753 |
31 Mar 18 | 36,073 | -5,352 | 11,896 | 1,673 |
31 Dec 17 | 34,868 | -5,128 | 11,562 | 1,527 |
31 Dec 16 | 27,243 | 7,072 | 9,043 | 1,079 |
31 Dec 14 | 13,058 | 2,515 | 5,818 | 0 |
Quality Earnings: A214150 has high quality earnings.
Growing Profit Margin: A214150's current net profit margins (39.4%) are lower than last year (51%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A214150's earnings have grown significantly by 23.1% per year over the past 5 years.
Accelerating Growth: A214150's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A214150 had negative earnings growth (-4.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (-13.3%).
Return on Equity
High ROE: A214150's Return on Equity (24.8%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 20:13 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CLASSYS Inc. is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Heejin Lim | Citigroup Inc |
Sanjeev Rana | CLSA |
Dong Cheol Shin | CLSA |